|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2004
Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units
1 Adult Cystic Fibrosis Unit, The Prince Charles Hospital, 2 Clinical Virology Research Unit, Sir Albert Sakzewski Virology Research Centre, 3 Dept of Respiratory Medicine, Royal Children's Hospital, 4 Paediatric and Child Health, 6 Dept of Medicine, University of Queensland and 5 Queensland Health Pathology Service, Queensland Health, Brisbane, Australia
CORRESPONDENCE: S.C. Bell, Thoracic Physician, Dept of Thoracic Medicine, The Prince Charles Hospital, Rode Road, Chermside 4032, Australia. Fax: 61 732125630. E-mail: scott_bell@health.qld.gov.au
Keywords: Clonal strain, cystic fibrosis, Pseudomonas aeruginosa, pulsed-field gel electrophoresis
Received: November 2, 2003
Accepted February 13, 2004
This study was supported by the Royal Children's Hospital Foundation Seeding grant R912-007, which was sponsored by the Cressbrook Committee.
Despite recent reports of clonal strains of Pseudomonas aeruginosa in cystic fibrosis (CF) units, the need for routine microbiological surveillance remains contentious.
Sputum was collected prospectively from productive patients attending the regional paediatric and adult CF units in Brisbane, Australia. All P. aeruginosa isolates were typed using pulsed-field gel electrophoresis. Spirometry, anthropometrics, hospitalisations and antibiotic sensitivity data were recorded.
The first 100 sputum samples (first 50 patients at each clinic) harboured 163 isolates of P. aeruginosa. A total of 39 patients shared a common strain (pulsotype 2), 20 patients shared a strain with at least one other patient and 41 patients harboured unique strains. Eight patients shared a strain identical to a previously reported Australian transmissible strain (pulsotype 1). Compared with the unique strain group, patients harbouring pulsotype 2 were younger and had poorer lung function. Treatment requirements were similar in these two groups, as were the rates of multiresistance.
In conclusion, 59% of patients harboured a clonal strain, supporting the need for routine microbiological surveillance. In contrast to previously described clonal strains, the dominant pulsotype was indistinguishable from nonclonal strains with respect to both colonial morphology and multiresistance. The clinical significance of clonal strains remains uncertain and requires longitudinal study.
This article has been cited by other articles:
|
|
 |
|
  T. J. Kidd, K. A. Ramsay, H. Hu, P. T. P. Bye, M. R. Elkins, K. Grimwood, C. Harbour, G. B. Marks, M. D. Nissen, P. J. Robinson, et al. Low Rates of Pseudomonas aeruginosa Misidentification in Isolates from Cystic Fibrosis Patients J. Clin. Microbiol., May 1, 2009; 47(5): 1503 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Winstanley, M. G.I. Langille, J. L. Fothergill, I. Kukavica-Ibrulj, C. Paradis-Bleau, F. Sanschagrin, N. R. Thomson, G. L. Winsor, M. A. Quail, N. Lennard, et al. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa Genome Res., January 1, 2009; 19(1): 12 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Schmid, L. J. Ling, J. L. S. Leung, N. Zhang, J. Kolbe, A. W. Wesley, G. D. Mills, P. J. Brown, D. T. Jones, R. T. R. Laing, et al. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics Eur. Respir. J., December 1, 2008; 32(6): 1583 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Manos, J. Arthur, B. Rose, P. Tingpej, C. Fung, M. Curtis, J. S. Webb, H. Hu, S. Kjelleberg, M. D. Gorrell, et al. Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung J. Med. Microbiol., December 1, 2008; 57(12): 1454 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Vu-Thien, G. Corbineau, K. Hormigos, B. Fauroux, H. Corvol, A. Clement, G. Vergnaud, and C. Pourcel Multiple-Locus Variable-Number Tandem-Repeat Analysis for Longitudinal Survey of Sources of Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients J. Clin. Microbiol., October 1, 2007; 45(10): 3175 - 3183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tingpej, L. Smith, B. Rose, H. Zhu, T. Conibear, K. Al Nassafi, J. Manos, M. Elkins, P. Bye, M. Willcox, et al. Phenotypic Characterization of Clonal and Nonclonal Pseudomonas aeruginosa Strains Isolated from Lungs of Adults with Cystic Fibrosis J. Clin. Microbiol., June 1, 2007; 45(6): 1697 - 1704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jelsbak, H. K. Johansen, A.-L. Frost, R. Thogersen, L. E. Thomsen, O. Ciofu, L. Yang, J. A. J. Haagensen, N. Hoiby, and S. Molin Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients Infect. Immun., May 1, 2007; 75(5): 2214 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Smith, B. Rose, P. Tingpej, H. Zhu, T. Conibear, J. Manos, P. Bye, M. Elkins, M. Willcox, S. Bell, et al. Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. J. Med. Microbiol., December 1, 2006; 55(Pt 12): 1641 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. M. Smart, F. W. Scott, E. A. Wright, M. J. Walshaw, C. A. Hart, T. L. Pitt, and C. Winstanley Development of a diagnostic test for the Midlands 1 cystic fibrosis epidemic strain of Pseudomonas aeruginosa. J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1085 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. M. Smart, M. J. Walshaw, C. A. Hart, and C. Winstanley Use of suppression subtractive hybridization to examine the accessory genome of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa J. Med. Microbiol., June 1, 2006; 55(6): 677 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chambers, F. Scott, R. Bangur, R. Davies, A. Lim, S. Walters, G. Smith, T. Pitt, D. Stableforth, and D. Honeybourne Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Eur. Respir. J., October 1, 2005; 26(4): 651 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Jones Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered Eur. Respir. J., September 1, 2005; 26(3): 373 - 375. [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Griffiths, K. Jamsen, J. B. Carlin, K. Grimwood, R. Carzino, P. J. Robinson, J. Massie, and D. S. Armstrong Effects of Segregation on an Epidemic Pseudomonas aeruginosa Strain in a Cystic Fibrosis Clinic Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 1020 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Jones, M. E. Dodd, J. R. W. Govan, C. J. Doherty, C. M. Smith, B. J. Isalska, and A. K. Webb Prospective Surveillance for Pseudomonas aeruginosa Cross-Infection at a Cystic Fibrosis Center Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 257 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W Syrmis, M. R O'Carroll, T. P Sloots, C. Coulter, C. E Wainwright, S. C Bell, and M. D Nissen Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays J. Med. Microbiol., November 1, 2004; 53(11): 1089 - 1096. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |